<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-27T10:19:06Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/12761" metadataPrefix="mods">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/12761</identifier><datestamp>2025-08-28T12:43:51Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Vicario De La Torre, Marta</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Caballo González, María</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Vico Ruiz, Eva</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Morales Fernández, Laura</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Arriola Villalobos, Pedro</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Heras Polo, Beatriz De Las</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Benítez Del Castillo Sánchez, José Manuel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Guzmán Navarro, Manuel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Millar, Thomas</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Herrero Vanrell, María Del Rocío</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Molina Martínez, Irene Teresa</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2023-06-17T12:40:43Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2023-06-17T12:40:43Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2018</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="citation">Vicario-de-la-Torre M, Caballo-González M, Vico E, Morales-Fernández L, Arriola-Villalobos P, De Las Heras B, et al. Novel Nano-Liposome Formulation for Dry Eyes with Components Similar to the Preocular Tear Film. Polymers 2018;10:425. https://doi.org/10.3390/polym10040425.</mods:identifier>
   <mods:identifier type="issn">2073-4360</mods:identifier>
   <mods:identifier type="doi">10.3390/polym10040425</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/20.500.14352/12761</mods:identifier>
   <mods:identifier type="officialurl">https://doi.org/10.3390/polym10040425</mods:identifier>
   <mods:abstract>Dry eye is commonly treated with artificial tears; however, developing artificial tears similar to natural tears is difficult due to the complex nature of tears. We characterized and evaluated a novel artificial tear formulation with components similar to the lipid and aqueous constituents of natural tears. Nano-liposomes, composed in part of phosphatidylcholine, were dispersed in an aqueous solution of bioadhesive sodium hyaluronate. Liposome size, zeta potential, and physicochemical properties of the fresh and stored (4°C) liposomal formulation were analyzed. In vitro tolerance was tested using human corneal and conjunctival cell lines by exposures of 15 min to 4 h. The tolerance of the liposomal formulation was evaluated in animals (rabbits). The average liposome size was 186.3 +/- 7.0 nm, and the zeta potential was negative. The osmolarity of the formulation was 198.6 +/- 1.7 mOsm, with a surface tension of 36.5 +/- 0.4 mN/m and viscosity of 3.05 +/- 0.02 mPa·s. Viability values in the human corneal and conjunctival cell lines were always >80%, even after liposomal formulation storage for 8 weeks. Discomfort and clinical signs after instillation in rabbit eyes were absent. The new formulation, based on phosphatidylcholine-liposomes dispersed in sodium hyaluronate has suitable components and characteristics, including high in vitro cell viability and good in vivo tolerance, to serve as a tear substitute.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">https://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">ATTRIBUTION 4.0 INTERNATIONAL
</mods:accessCondition>
   <mods:titleInfo>
      <mods:title>Novel Nano-Liposome Formulation for Dry Eyes with Components Similar to the Preocular Tear Film</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>